6-(aminomethyl)-7-(2,4-dichlorophenyl)-N-(2-methoxyethyl)-N,5-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine

ID: ALA1209766

Chembl Id: CHEMBL1209766

PubChem CID: 11654093

Max Phase: Preclinical

Molecular Formula: C17H20Cl2N6O

Molecular Weight: 395.29

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCN(C)c1nc2nc(C)c(CN)c(-c3ccc(Cl)cc3Cl)n2n1

Standard InChI:  InChI=1S/C17H20Cl2N6O/c1-10-13(9-20)15(12-5-4-11(18)8-14(12)19)25-16(21-10)22-17(23-25)24(2)6-7-26-3/h4-5,8H,6-7,9,20H2,1-3H3

Standard InChI Key:  KRWYTIWWBMYZRH-UHFFFAOYSA-N

Associated Targets(Human)

DPP4 Tclin Dipeptidyl peptidase IV (7109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DPP8 Tchem Dipeptidyl peptidase VIII (2139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DPP9 Tchem Dipeptidyl peptidase IX (1624 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.29Molecular Weight (Monoisotopic): 394.1076AlogP: 2.95#Rotatable Bonds: 6
Polar Surface Area: 81.57Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.97CX LogP: 2.98CX LogD: 1.42
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.69Np Likeness Score: -1.61

References

1. Brigance RP, Meng W, Fura A, Harrity T, Wang A, Zahler R, Kirby MS, Hamann LG..  (2010)  Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes.,  20  (15): [PMID:20598534] [10.1016/j.bmcl.2010.06.063]
2. Kumar S, Mittal A, Mittal A..  (2021)  A review upon medicinal perspective and designing rationale of DPP-4 inhibitors.,  46  [PMID:34428715] [10.1016/j.bmc.2021.116354]

Source